Aumgene Biosciences
U24231GJ2004PTC044192ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed
Aumgene Biosciences is a Private Indian company incorporated in 2004 and based in Gujarat, India. Aumgene Biosciences operates in is Nutraceuticals Tech (NIC 24231) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2004
22 years old
State
Gujarat
Sector
is Nutraceuticals Tech
NIC 24231
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
Aumgene BiosciencesTRACXN · PUBLIC DATA
Brand Aumgene Biosciences · Legal entity Aumgene Biosciences
Aumgene Biosciences - Manufacturer of enzymes, probiotics, and microbial biofertilizers for various applications. Raised a total funding of $12.9K over 1 round from 19 investors.
Total Funding
Latest Round
Seed
Revenue
Valuation
Funding Rounds
—
Employees
44
Stage
Seed
HQ
Surat
Founded
2004
Source: Tracxn (public profile) · joined to MCA on CIN U24231GJ2004PTC044192
Quick facts
Registered office
—
NIC code
24231
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
is Nutraceuticals Tech
ROC
—
Website
Class · sub-category
Private
Incorporation · Last AGM
— · —
Directors
LockedRK
Rajesh Kumar Sharma
Director8.2y · Ahmedabad · DIN 4984831
AD
Anita Desai
Director5.4y · New Delhi · DIN 7165901
MK
Meera Krishnan
Managing Director7.1y · Bengaluru · DIN 5591743
Get the full board of directors
Directors, DINs & appointment history for Aumgene Biosciences.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +2d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Aumgene Biosciences.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 452652944 | State Bank of India(Bank) | ₹14.81 Cr | 19 Sep 2021 | Open |
| 963337335 | State Bank of India(Bank) | ₹1.92 Cr | 12 Mar 2019 | Open |
| 271285877 | ICICI Bank Ltd(Bank) | ₹21.47 Cr | 19 Sep 2023 | Open |
| 202587535 | State Bank of India(Bank) | ₹13.70 Cr | 12 Mar 2019 | Open |
| 793999140 | Kotak Mahindra Bank Ltd(Bank) | ₹15.90 Cr | 19 Sep 2020 | Satisfied |
See registered charges & lenders
Charge IDs, lenders & amounts for Aumgene Biosciences.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹10.62 Cr | ₹-24.60 L | ₹6.33 Cr | ₹12.43 Cr | 123 |
| FY2023-24 | ₹8.61 Cr | ₹-13.58 L | ₹3.96 Cr | ₹7.94 Cr | 284 |
| FY2022-23 | ₹9.22 Cr | ₹-22.59 L | ₹5.01 Cr | ₹11.05 Cr | 203 |
| FY2021-22 | ₹6.60 Cr | ₹-16.75 L | ₹5.06 Cr | ₹7.39 Cr | 116 |
Gain deeper financial insights of this entity
Audited financials & ratios for Aumgene Biosciences.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹10.62 Cr | ₹8.61 Cr | ₹9.22 Cr | ₹6.60 Cr |
| Other income | ₹14.22 L | ₹4.68 L | ₹13.46 L | ₹11.84 L |
| Total income | ₹10.76 Cr | ₹8.66 Cr | ₹9.35 Cr | ₹6.71 Cr |
| Total expenses | ₹11.07 Cr | ₹8.83 Cr | ₹9.64 Cr | ₹6.93 Cr |
| Profit before tax | ₹-31.98 L | ₹-17.65 L | ₹-29.37 L | ₹-21.77 L |
| Profit / (Loss) after tax | ₹-24.60 L | ₹-13.58 L | ₹-22.59 L | ₹-16.75 L |
| Balance sheet | ||||
| Equity / Net worth | ₹6.33 Cr | ₹3.96 Cr | ₹5.01 Cr | ₹5.06 Cr |
| Borrowings | ₹1.44 Cr | ₹1.92 Cr | ₹1.46 Cr | ₹1.13 Cr |
| Current liabilities | ₹2.47 Cr | ₹2.26 Cr | ₹2.01 Cr | ₹1.14 Cr |
| Total liabilities | ₹6.11 Cr | ₹3.98 Cr | ₹6.04 Cr | ₹2.33 Cr |
| Current assets | ₹6.82 Cr | ₹3.76 Cr | ₹5.92 Cr | ₹3.56 Cr |
| Cash & equivalents | ₹90.04 L | ₹88.69 L | ₹85.37 L | ₹1.26 Cr |
| Total assets | ₹12.43 Cr | ₹7.94 Cr | ₹11.05 Cr | ₹7.39 Cr |
| Employees | 123 | 284 | 203 | 116 |
Gain deeper financial insights of this entity
Audited financials & ratios for Aumgene Biosciences.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹10.62 Cr | -8.7% | -5.2% | +19.3% |
| Profit after Tax | ₹-24.60 L | -3.5% | +0.2% | -2.4% |
| Net Worth | ₹6.33 Cr | -7.7% | +7.8% | +5.1% |
| Employees | 123 | +12.9% | -0.6% | +6.3% |
Gain deeper financial insights of this entity
Audited financials & ratios for Aumgene Biosciences.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹10.62 Cr | ₹-24.60 L | -2.32% | -8.91% | -3.89% | -1.98% | 0.23 | ₹8.63 L |
| FY2023-24 | ₹8.61 Cr | ₹-13.58 L | -1.58% | +20.39% | -3.43% | -1.71% | 0.49 | ₹3.03 L |
| FY2022-23 | ₹9.22 Cr | ₹-22.59 L | -2.45% | -10.01% | -4.51% | -2.05% | 0.29 | ₹4.54 L |
| FY2021-22 | ₹6.60 Cr | ₹-16.75 L | -2.54% | +31.93% | -3.31% | -2.26% | 0.22 | ₹5.69 L |
Gain deeper financial insights of this entity
Audited financials & ratios for Aumgene Biosciences.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,61,61,498 | 90.68% |
| Institutional Investors | 2 | 11,66,354 | 4.04% |
| Public & Others | 8 | 15,21,148 | 5.27% |
See the full shareholding pattern
Promoter, institutional & public holding for Aumgene Biosciences.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
LockedMetricThis companyCohort medianCohort P75Quartile
Revenue
₹10.62 Cr
₹10.34 Cr
₹17.01 Cr
2nd quartile · P53
PAT margin
-2.3%
4.7%
19.0%
2nd quartile · P61
Net worth
₹6.33 Cr
₹6.80 Cr
₹10.60 Cr
Top quartile · P78
Debt / equity
0.23
0.73
0.44
3rd quartile · P29
Gain deeper financial insights of this entity
Audited financials & ratios for Aumgene Biosciences.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Aumgene Biosciences
When was Aumgene Biosciences incorporated?
Aumgene Biosciences was incorporated in 2004. Its CIN is U24231GJ2004PTC044192 and it is registered with the relevant Registrar of Companies.
Where is Aumgene Biosciences located?
Aumgene Biosciences is headquartered in Gujarat.
What sector does Aumgene Biosciences operate in?
Aumgene Biosciences operates in the is Nutraceuticals Tech sector (NIC code 24231), classified as Indian Non-Govt Company.
Who are the directors of Aumgene Biosciences?
Director details for Aumgene Biosciences have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Aumgene Biosciences?
Aumgene Biosciences has authorized capital of — and paid-up capital of —.
Does Aumgene Biosciences have any open charges?
Aumgene Biosciences has no open MCA-registered charges on record.
What is Aumgene Biosciences's Compliance Health Score?
RegisterKaro's Compliance Health Score for Aumgene Biosciences is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.